FDA Issues Guidance on Nanotechnology Use in Industry

Share this content:
FDA Issues Guidance on Nanotechnology Use in Industry
FDA Issues Guidance on Nanotechnology Use in Industry

(HealthDay News) -- The U.S. Food and Drug Administration has released three final guidance documents and one draft guidance document in an effort to provide greater regulatory clarity for industry on the use of nanotechnology.

Noting that nanotechnology has a wide range of potential applications, the FDA has provided guidance relating to nanotechnology use in industry, with specific guidance for foods, cosmetics, and foods for animals.

RELATED: Might Nano-oncology Resurrect Old Anticancer Drugs?

The final and draft guidance documents relate to use of nanotechnology in FDA-regulated products. One of the final guidance documents for industry outlines points to consider when determining whether a product involves nanotechnology, and should help industry and others to know when to consider potential implications for regulatory status, safety, effectiveness, or public health impact.

Another final guidance document describes safety assessments of nanomaterials when used in cosmetic products. The third final guidance document relates to assessing the effects of manufacturing process changes, including nanotechnology, on the safety and regulatory status of food substances. The draft guidance document relates to the use of nanotechnology in food ingredients intended for animal food.

RELATED: Nanotechnology: The Evolution of Cancer Drug Delivery

"Our goal remains to ensure transparent and predictable regulatory pathways, grounded in the best available science, in support of the responsible development of nanotechnology products," FDA Commissioner Margaret A. Hamburg, MD, said in a statement.

"We are taking a prudent scientific approach to assess each product on its own merits and are not making broad, general assumptions about the safety of nanotechnology products."

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs